Filing Details

Accession Number:
0000885590-10-000063
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-02 21:35:43
Reporting Period:
2010-12-01
Filing Date:
2010-12-02
Accepted Time:
2010-12-02 21:35:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1453140 Rajiv Silva De C/O 7150 Mississauga Road
Mississauga A6 L5N 8M5
President & Coo Spec. Pharma. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2010-12-01 18,277 $8.11 511,691 No 4 M Direct
Common Shares, No Par Value Disposition 2010-12-01 18,277 $27.00 493,414 No 4 S Direct
Common Shares, No Par Value Disposition 2010-12-01 201,620 $27.00 291,794 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares, No Par Value Non-Qualified Stock Options (right to purchase) Disposition 2010-12-01 18,277 $0.00 18,277 $8.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
208,743 2010-01-05 2019-01-05 No 4 M Direct
Footnotes
  1. Stock Options were exercised and underlying Common Stock sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on August 8, 2010.
  2. Restricted Share Units were sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on June 29, 2009.